BARINTHUS BIOTHERAPEUTICS PLC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 614.23K shares, a 257.15% increase from fiscal 2024.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 171.98K shares, a 137.59% increase from fiscal 2023.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 72.39K shares, a 61.43% decline from fiscal 2022.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 187.66K shares, a 3.18% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 614.23K shares 10-K · filed 2026-03-13 | |
| 2024-12-31 | 171.98K shares 10-K · filed 2025-03-20 | |
| 2023-12-31 | 72.39K shares 10-K · filed 2024-03-20 | |
| 2022-12-31 | 187.66K shares 10-K · filed 2023-03-24 | |
| 2021-12-31 | 181.88K shares 10-K · filed 2022-03-25 |